[HTML][HTML] Viral and host factors related to the clinical outcome of COVID-19
…, X Jia, M Wu, B Shi, S Xu, J Chen, W Wang, B Chen… - Nature, 2020 - nature.com
In December 2019, coronavirus disease 2019 (COVID-19), which is caused by the new
coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in …
coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in …
[HTML][HTML] Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies
G Zhou, S Chen, Z Chen - Frontiers of medicine, 2020 - Springer
Since the outbreak of the COVID-19 pandemic in early December 2019, 81 174 confirmed
cases and 3242 deaths have been reported in China as of March 19, 2020. The Chinese …
cases and 3242 deaths have been reported in China as of March 19, 2020. The Chinese …
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
…, D Yu, J Hou, Z Shi, S Chen, Z Chen… - Proceedings of the …, 2020 - National Acad Sciences
Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019
(COVID-19). In this study, 10 severe patients confirmed by real-time viral RNA test were …
(COVID-19). In this study, 10 severe patients confirmed by real-time viral RNA test were …
Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic
X Zhang, W Zhang, S Chen - The Lancet, 2022 - thelancet.com
… Saijuan Chen … Zhang X, Zhang W, Chen S. Shanghai's life-saving efforts against the
current omicron wave of the COVID-19 pandemic. Lancet 2022; published online May 6. …
current omicron wave of the COVID-19 pandemic. Lancet 2022; published online May 6. …
[HTML][HTML] Design of wide-spectrum inhibitors targeting coronavirus main proteases
…, KY Yuen, L Wong, G Gao, S Chen, Z Chen… - PLoS …, 2005 - journals.plos.org
The genus Coronavirus contains about 25 species of coronaviruses (CoVs), which are
important pathogens causing highly prevalent diseases and often severe or fatal in humans and …
important pathogens causing highly prevalent diseases and often severe or fatal in humans and …
Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions
…, S Liu, M Xiang, S Li, D Zhao, C Huang, S Chen - Frontiers of …, 2020 - Springer
… Zhiruo Zhang, Shelan Liu, Mi Xiang, Shijian Li, Dahai Zhao, Chaolin Huang, and Saijuan
Chen declare no conflicts of interest. This manuscript is a commentary and does not involve a …
Chen declare no conflicts of interest. This manuscript is a commentary and does not involve a …
Hiplot: a comprehensive and easy-to-use web service for boosting publication-ready biomedical data visualization
…, XS Liu, R Wu, Y Shen, Z Chen, S Chen… - Briefings in …, 2022 - academic.oup.com
Complex biomedical data generated during clinical, omics and mechanism-based experiments
have increasingly been exploited through cloud- and visualization-based data mining …
have increasingly been exploited through cloud- and visualization-based data mining …
From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia
SJ Chen, GB Zhou, XW Zhang, JH Mao… - Blood, The Journal …, 2011 - ashpublications.org
Arsenic had been used in treating malignancies from the 18th to mid-20th century. In the past
3 decades, arsenic was revived and shown to be able to induce complete remission and to …
3 decades, arsenic was revived and shown to be able to induce complete remission and to …
The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study
…, D Zhou, D Yu, J Hou, Z Shi, C Saijuan, Z Chen… - MedRxiv, 2020 - medrxiv.org
Currently, there are no approved specific antiviral agents for 2019 novel coronavirus disease
(COVID-19). In this study, ten severe patients confirmed by real-time viral RNA test were …
(COVID-19). In this study, ten severe patients confirmed by real-time viral RNA test were …
Arsenic trioxide, a therapeutic agent for APL
…, GQ Chen, ZG Wang, ZY Wang, SJ Chen, Z Chen - Oncogene, 2001 - nature.com
Acute promyelocytic leukemia (APL) is an interesting model in cancer research, because it
can respond to the differentiation/apoptosis induction therapy using all-trans retinoic acid (…
can respond to the differentiation/apoptosis induction therapy using all-trans retinoic acid (…